Submitted by Anonymous (not verified) on 1 July 2025 - 10:08
Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised